First Header Logo Second Header Logo

Connection

Joseph Yeboah to Diabetes Mellitus, Type 2

This is a "connection" page, showing publications Joseph Yeboah has written about Diabetes Mellitus, Type 2.
Connection Strength

1.309
  1. Branch M, German C, Bertoni A, Yeboah J. Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial. J Diabetes Complications. 2019 07; 33(7):468-472.
    View in: PubMed
    Score: 0.361
  2. Yeboah P, Hsu FC, Bertoni AG, Yeboah J. Body Mass Index, Change in Weight, Body Weight Variability and Outcomes in Type 2 Diabetes Mellitus (from the ACCORD Trial). Am J Cardiol. 2019 02 15; 123(4):576-581.
    View in: PubMed
    Score: 0.352
  3. Yeboah J, Sane DC, Crouse JR, Herrington DM, Bowden DW. Low plasma levels of FGF-2 and PDGF-BB are associated with cardiovascular events in type II diabetes mellitus (diabetes heart study). Dis Markers. 2007; 23(3):173-8.
    View in: PubMed
    Score: 0.154
  4. Mayl JJ, German CA, Bertoni AG, Upadhya B, Bhave PD, Yeboah J, Singleton MJ. Association of Alcohol Intake With Hypertension in Type 2 Diabetes Mellitus: The ACCORD Trial. J Am Heart Assoc. 2020 09 15; 9(18):e017334.
    View in: PubMed
    Score: 0.100
  5. Dhaliwal KK, Upadhya B, Soliman EZ, Beaty EH, Yeboah J, Bhave PD, Whalen SP, Singleton MJ. Association of P-Wave Axis With Incident Atrial Fibrillation in Diabetes Mellitus (from the ACCORD Trial). Am J Cardiol. 2020 08 01; 128:191-195.
    View in: PubMed
    Score: 0.097
  6. Yeboah J, Sillau S, Delaney JC, Blaha MJ, Michos ED, Young R, Qureshi WT, McClelland R, Burke GL, Psaty BM, Herrington DM. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2015 Mar; 169(3):387-395.e3.
    View in: PubMed
    Score: 0.067
  7. Yeboah J, Erbel R, Delaney JC, Nance R, Guo M, Bertoni AG, Budoff M, Moebus S, Jöckel KH, Burke GL, Wong ND, Lehmann N, Herrington DM, Möhlenkamp S, Greenland P. Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Atherosclerosis. 2014 Oct; 236(2):411-7.
    View in: PubMed
    Score: 0.065
  8. Cox AJ, Azeem A, Yeboah J, Soliman EZ, Aggarwal SR, Bertoni AG, Carr JJ, Freedman BI, Herrington DM, Bowden DW. Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the Diabetes Heart Study. Diabetes Care. 2014 May; 37(5):1454-61.
    View in: PubMed
    Score: 0.063
  9. Doran AC, Lehtinen AB, Meller N, Lipinski MJ, Slayton RP, Oldham SN, Skaflen MD, Yeboah J, Rich SS, Bowden DW, McNamara CA. Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans. Circ Res. 2010 Apr 16; 106(7):1303-11.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.